Correction for partial-volume effects on brain perfusion SPECT in healthy men

Journal of Nuclear Medicine

Volumn 44, Issue 8, 2003, Pages 1243-1252

  Matsuda, Hiroshi ^a   Ohnishi, Takashi ^a   Asada, Takashi ^b   Li, Zhi Jie ^a,c   Kanetaka, Hidekazu ^a   Imabayashi, Etsuko ^a   Tanaka, Fumiko ^a   Nakano, Seigo ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Aging; MRI; Partial volume effects; SPECT; Statistical parametric mapping

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; CYSTEINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; RADIOPHARMACEUTICAL AGENT; TECHNETIUM COMPLEX; TECHNETIUM TC 99M BICISATE;

ACCURACY; ADULT; AGED; ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; BRAIN SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; FRONTAL CORTEX; GRAY MATTER; HUMAN; IMAGE ANALYSIS; MALE; NORMAL HUMAN; PARIETAL LOBE; PHANTOM; PRIORITY JOURNAL; SENSORIMOTOR CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STANDARDIZATION; STATISTICAL SIGNIFICANCE; SUPRASYLVIAN GYRUS; TEMPORAL LOBE; THREE DIMENSIONAL IMAGING; VALIDATION PROCESS; ADOLESCENT; AGING; ALGORITHM; ARTIFACT; BRAIN; BRAIN CIRCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; IMAGE ENHANCEMENT; IMAGE QUALITY; IMAGE SUBTRACTION; INSTRUMENTATION; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; QUALITY CONTROL; REFERENCE VALUE; SCINTISCANNING; VALIDATION STUDY; VASCULARIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ALGORITHMS; ARTIFACTS; BRAIN; CEREBROVASCULAR CIRCULATION; CYSTEINE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PHANTOMS, IMAGING; QUALITY CONTROL; RADIOPHARMACEUTICALS; REFERENCE VALUES; SUBTRACTION TECHNIQUE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0141446426     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Mueller-Gaertner HW, Links JM, Prince JL, et al. Measurement of radiotracer concentration in brain gray matter using positron emission tomography: MRI-based correction for partial volume effects. J Cereb Blood Flow Metab. 1992; 12:571-583.
2. Labbe C, Froment JC, Kennedy A, Ashbumer J, Cinotti I. Positron emission tomography metabolic data corrected for cortical atrophy using magnetic resonance imaging. Alzheimer Dis Assoc Disord. 1996;10:141-170.
3. Meltzer CC, Zubieta JK, Brandt J, Tune LE, Mayberg HS, Frost JJ. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction tor effects of partial volume averaging. Neurology. 1996;47:454-461.
4. Ibanez V, Pietrini P, Alexander GE, et al. Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease. Neurology 1998;50: 1585-1593.
5. Matsuda H, Kanetaka H, Ohnishi T, et al. Brain SPET abnormalities in Alzheimer's disease before and after atrophy correction. Eur J Nucl Med. 2002;29: 1502-1505.
6. Wechsler D. Wechsler Memory Scale-Revised, Manual. New York, NY: The Psychological Corp., 1987:10-57.
7. Wechsler D. Wechsler Adult Intelligence Scale-Revised, Manual. Cleveland, OH: The Psychological Corp.; 1981:69-128.
8. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
9. Matsuda H, Yagishita A, Tsuji S, Hisada K. A quantitative approach to technetium-99m ethyl cysteinate dimer, a comparison with technetium-99m hexamethylpropylene amine oxime Eur J Nucl Med. 1995;22:633-637.
10. 99mTc-bicisate in the human brain after intracarotid injection. J Cereb Blood Flow Metab. 1994;14(suppl 1):S19-S27.
11. Woods RP, Grafton ST, Holmes CJ, Cherry SR, Mazziotta JC. Automated image registration. I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr. 1998;22:141-154.
12. Woods RP, Grafton ST, Watson JDG, Sicotte NL, Mazziotta JC. Automated image registration. II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr. 1998;22:153-165.
13. Ashburner J, Friston KJ. Voxel-based morphometry: the methods. Neuroimage. 2000;11:805-821.
14. Hoffman EJ, Cutler PD, Diby WM, Mazziota JC. Three dimensional phantom to simulate cerebral blood flow and metabolic images for PET IEEE Trans Nucl Sci. 1990;37:616-620.
15. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York, NY: Thieme Medical; 1988.
16. Ohnishi T, Matsuda H, Hashimoto T, et al. Abnormal regional cerebral blood flow in childhood autism. Brain. 2000;123:1838-1844.
17. Frith CD, Friston KJ, Ashburner J, et al. Principles and methods. In: Frackowiak RSJ, Friston KJ, Frith CD, Dolan RJ, Mazziotta JC, eds. Human Brain Function. San Diego, CA: Academic Press; 1997:3-159.
18. 99mTc-ECD SPET. Eur J Nucl Med Mol Imaging. 2002;29:331-341.
19. Ohnishi T, Matsuda H, Tabira T, Asada T, Uno M. Changes in brain morphology in Alzheimer disease and normal aging, is Alzheimer disease an exaggerated aging process? AJNR. 2001;22:1680-1685.
20. Meltzer CC, Kinahan PE, Greer PJ, et al. Comparative evaluation of MR-based partial volume correction schemes for PET. J Nucl Med 1999;40:2053-2065.
21. Minoshima S, Frey KA, Koeppe RA, et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med. 1995;36:1238-1248
22. Martin AJ, Friston KJ, Colebatch JG, Frackowiak RSJ. Decreases in regional cerebral blood flow with normal aging. J Cereb Blood Flow Metab. 1991;11: 684-689.
23. Petit-Taboue MC, Landeau B, Desson JF, Desgranges B, Baron JC. Effects of healthy aging on the regional cerebral metabolic rate of glucose assessed with statistical parametric mapping. Neuroimage. 1998;7:176-184.
24. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET Neuroimage. 2002;17:302-316.
25. Baron JC, Godeau C. Human aging. In: Toga A, Mazziotta JC, eds. Brain Mapping: The Systems. San Diego, CA: Academic Press; 2000:591-604.
26. 99mTc-HMPAO SPET in healthy subjects at rest normal distribution and effect of age and gender. Eur J Nucl Med. 2002; 29:67-75.
27. 99mTc-ECD brain perfusion SPET: variability, asymmetry and effects of age and gender in healthy adults. Eur J Nucl Med. 2001;28:873-887.
28. Meltzer CC, Cantwell MN, Greer PJ, et al. Does cerebral blood flow decline in healthy aging? a PET study with partial-volume correction. J Nucl Med. 2000; 41:842-1848.
29. Roland PE. The frontal lobes and limbic system. In: Roland PE, ed. Brain Activation. New York, NY: Wiley-Liss; 1993:341-364.
30. Craik FIM, Grady CL. Aging, memory, and frontal lobe functioning. In: Stuss DT, Knight RT, eds. Principles of Frontal Lobe Function. New York, NY: Oxford University Press; 2002:528-540.
31. Good CD, Johnsrude IS, Ashbumer J, Henson RNA, Friston KJ, Frackowiak RSJ. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14:21-36.
32. Raz N, Gunning FM, Head D, et al. Selective aging of the human cerebral cortex observed in vivo: differential vulnerability of the prefrontal gray matter. Cereb Cortex, 1997;7:268-282.
33. Van Laere KJ, Dierckx RA. Brain perfusion SPECT: age- and sex-related effects correlated with voxel-based morphometric findings in healthy adults. Radiology. 2001;221:810-817